Search:

Results 1 to 5 of 5

Extra life : a short history of living longer / by Johnson, Steven,1968-author.;
Includes bibliographical references and index."As a species, humans have doubled their life expectancy in one hundred years. Medical breakthroughs, public health institutions, rising standards of living, and the other advances of modern life have given each person about 20,000 extra days on average. This book attempts to help the reader understand where that progress came from and what forces keep people alive longer. The author also considers how to avoid decreases in life expectancy as public health systems face unprecedented challenges, and what current technologies or interventions could reduce the impact of future crises"--
Subjects: Health services administration; Life expectancy.; Public health administration;
Available copies: 1 / Total copies: 1
unAPI

The premonition : a pandemic story / by Lewis, Michael(Michael M.),author.;
"For those who could read between the lines, the censored news out of China was terrifying. But the president insisted there was nothing to worry about. Fortunately, we are still a nation of skeptics. Fortunately, there are those among us who study pandemics and are willing to look unflinchingly at worst-case scenarios. Michael Lewis's taut and brilliant nonfiction thriller pits a band of medical visionaries against the wall of ignorance that was the official response of the Trump administration to the outbreak of COVID-19. The characters you will meet in these pages are as fascinating as they are unexpected. A thirteen-year-old girl's science project on transmission of an airborne pathogen develops into a very grown-up model of disease control. A local public-health officer uses her worm's-eye view to see what the CDC misses, and reveals great truths about American society. A secret team of dissenting doctors, nicknamed the Wolverines, has everything necessary to fight the pandemic: brilliant backgrounds, world-class labs, prior experience with the pandemic scares of bird flu and swine flu ... everything, that is, except official permission to implement their work. Michael Lewis is not shy about calling these people heroes for their refusal to follow directives that they know to be based on misinformation and bad science. Even the internet, as crucial as it is to their exchange of ideas, poses a risk to them. They never know for sure who else might be listening in"--
Subjects: COVID-19 (Disease); COVID-19 (Disease); Coronavirus infections;
Available copies: 1 / Total copies: 1
unAPI

Doom : the politics of catastrophe / by Ferguson, Niall,author.;
Includes bibliographical references and index."Setting the great crisis of 2020 in broad historical perspective, Niall Ferguson challenges the conventional wisdom that our failure to cope better with disaster was solely a crisis of political leadership, as opposed to a more profound systemic problem. Disasters are by their very nature hard to predict. Pandemics, like earthquakes, wildfires, financial crises and wars, are not normally distributed; there is no cycle of history to help us anticipate the next catastrophe. But when disaster strikes, we ought to be better prepared than the Romans were when Vesuvius erupted, or medieval Italians when the Black Death struck. We have science on our side, after all. Yet the responses of a number of developed countries, including the United States, to a new pathogen from China were badly bungled. Why? The facile answer is to blame poor leadership. While populist leaders have certainly performed poorly in the face of the pandemic, more profound problems have been exposed by COVID-19. Only when we understand the central challenge posed by disaster in history can we see that this was also a failure of an administrative state and economic elites that had grown myopic over much longer than just a few years. Why were so many Cassandras for so long ignored? Why did only some countries learn the right lessons from SARS and MERS? Why do appeals to "the science" often turn out to be magical thinking? Drawing from multiple disciplines, including history, economics, public health, and network science, Doom is a global postmortem for a plague year. In books going back nearly twenty years, including Colossus, The Great Degeneration, and The Square and the Tower, Niall Ferguson has studied the pathologies that afflict modern America, from imperial hubris to bureaucratic sclerosis and online schism. Doom is the lesson of history that this country--indeed the West as a whole--urgently needs to learn--if we want to avoid the doom of irreversible decline"--
Subjects: COVID-19 (Disease); COVID-19 (Disease); Epidemics; Political leadership.;
Available copies: 1 / Total copies: 1
unAPI

The vaccine : inside the race to conquer the COVID-19 pandemic / by Miller, Joe(Correspondent),author.; Şahin, Uğur,1965-author.; Türeci, Özlem,author.;
Includes bibliographical references and index."Winners of the Paul Ehrlich Prize The dramatic story of the married scientists who founded BioNTech and developed the first vaccine against COVID-19. Nobody thought it was possible. In mid-January 2020, Ugur Sahin told Özlem Türeci, his wife and decades-long research partner, that a vaccine against what would soon be known as COVID-19 could be developed and safely injected into the arms of millions before the end of the year. His confidence was built upon almost thirty years of research. While working to revolutionize the way that cancerous tumors are treated, the couple had explored a volatile and overlooked molecule called messenger RNA; they believed it could be harnessed to redirect the immune system's forces against any number of diseases. As the founders of BioNTech, they faced widespread skepticism from the scientific community at first; but by the time Sars-Cov-2 was discovered in Wuhan, China, BioNTech was prepared to deploy cutting edge technology and create the world's first clinically approved inoculation for the coronavirus. The Vaccine draws back the curtain on one of the most important medical breakthroughs of our age; it will reveal how Doctors Sahin and Türeci were able to develop twenty vaccine candidates within weeks, convince Big Pharma to support their ambitious project, navigate political interference from the Trump administration and the European Union, and provide more than three billion doses of the Pfizer/BioNTech vaccine to countries around the world in record time. Written by Joe Miller-the Financial Times' Frankfurt correspondent who covered BioNTech's COVID-19 project in real time-with contributions from Sahin and Türeci, as well as interviews with more than sixty scientists, politicians, public health officials, and BioNTech staff, the book covers key events throughout the extraordinary year, as well as exploring the scientific, economic, and personal background of each medical innovation. Crafted to be both completely accessible to the average reader and filled with details that will fascinate seasoned microbiologists, The Vaccine explains the science behind the breakthrough, at a time when public confidence in vaccine safety and efficacy is crucial to bringing an end to this pandemic"--
Subjects: COVID-19 (Disease); Vaccines.;
Available copies: 1 / Total copies: 1
unAPI

Pain hustlers : crime and punishment at an opioid startup / by Hughes, Evan,1975-author.;
Includes bibliographical references."The blistering inside story of a startup that made millions pushing opioids--until its cutthroat tactics were exposed and its executives put behind bars. John Kapoor had amassed a small fortune in pharmaceuticals when he conceived of a new product. It was the 2000s, and opioids were big business. If Kapoor, an immigrant and the billionaire founder of Insys, could find a new way to administer the highly potent fentanyl, he could patent his invention and sell it to those in need--at a steep price. The only problem: There weren't enough people in need. Kapoor's drug was approved for breakthrough cancer pain. If Subsys was going to turn a profit, the company would need to persuade doctors to prescribe it 'off-label,' for other, lesser forms of pain. This is the story of how Insys turned a niche drug into big business. With executives leading the charge, Insys sales reps seduced doctors with charm, money, and sex. Its administrators lied to health care providers, claiming recipients had cancer when they did not. It pushed drugs onto patients that would have benefited from safer options, or no drugs at all. The strategy worked: When Insys went public, it notched the biggest IPO of its year. But several employees reached their limit and quietly blew the whistle, bringing the full force of the justice system upon the drug maker. In [Pain Hustlers], author and National Magazine Award-finalist Evan Hughes lays bare the pharma playbook. He shows how drug makers like Insys, fueled by greed and a hunger for market share, turn deception into profit. The book represents a stunning vindication, but also a cautionary tale. As Hughes shows, Insys didn't do anything its competitors weren't also doing. It was simply worse at covering its tracks."--
Subjects: Insys Therapeutics, Inc.; Advertising; Opioid abuse; Pharmaceutical industry; Pharmaceutical industry; Opioids;
Available copies: 1 / Total copies: 1
unAPI

Results 1 to 5 of 5